CONCURRENT SESSION ABSTRACTSCellular development integrating primary and induced secondary metabolism in the filamentous fungus Fusarium graminearum. Jon Menke 1 , JakobWeber 2 , Karen Broz 3 , H. Corby Kistler 1,3* . 1) Department of Plant Pathology, University of Minnesota, St. Paul, USA; 2) Molekulare Phytopathologie,Universität Hamburg, Germany; 3) USDA ARS Cereal Disease Laboratory, St. Paul, MN, USA.Several species of the filamentous fungus Fusarium colonize plants and produce toxic small molecules that contaminate agricultural products, renderingthem unsuitable for consumption. Among the most destructive of these species is F. graminearum, which causes disease in wheat and barley and oftencontaminates the grain with harmful trichothecene mycotoxins. Induction of these secondary metabolites occurs during plant infection or in culture inresponse to chemical signals. Here we report that trichothecene biosynthesis involves a complex developmental process that includes dynamic changes incell morphology and the biogenesis of novel subcellular structures. Two cytochrome P-450 oxygenases (Tri4p and Tri1p) involved in early and late steps intrichothecene biosynthesis were tagged with fluorescent proteins and shown to co-localize to vesicles we call “toxisomes.” Toxisomes, the inferred site oftrichothecene biosynthesis, dynamically interact with motile vesicles containing a predicted major facilitator superfamily protein (Tri12p) previouslyimplicated in trichothecene export and tolerance. The immediate isoprenoid precursor of trichothecenes is the primary metabolite farnesylpyrophosphate. When cultures are shifted from non-inducing to trichothecene inducing conditions, changes occur in the localization of the isoprenoidbiosynthetic enzyme HMG CoA reductase. Initially localized in the cellular endomembrane system, HMG CoA reductase increasingly is targeted totoxisomes. Metabolic pathways of primary and secondary metabolism thus may be coordinated and co-localized under conditions when trichothecenesynthesis occurs.LaeA sleuthing reveals cryptic gene clusters in pathogenic Aspergilli. Nancy Keller 2 , Wenbing Yin 2 , Saori Amaike 2 , Katharyn Affeld 2 , JinWoo Bok 2 , DanielSchwenk 3 , Dirk Hoffmeister 3 , Joshua Baccile 1 , Ry Forseth 1 , Frank Schroeder 1 . 1) Boyce Thompson Institute and Department of Chemistry and ChemicalBiology, Cornell University, Ithaca, NY 14853, USA; 2) Department of Plant Pathology, Department of Medical Microbiology and Immunology, andDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA; 3) Department of Pharmaceutical Biology at the Hans-Knöll-Institute, Friedrich-Schiller-Universität, Beutenbergstrabe 11a, 07745 Jena, Germany.The human and plant pathogenic Aspergilli, Aspergillus fumigatus and A. flavus, are known to produce a plethora of secondary metabolites. However,most of these metabolites are not yet characterized although their gene clusters are apparent from genomic sequence. In both species, the nuclearprotein LaeA regulates the expression of many of these uncharacterized gene clusters. Following leads from laeA mutant microarray data, we created genedeletion and overexpression strains and used 2D NMR-based comparative metabolomic analyses to identify previously undescribed metabolites from bothspecies. In A. fumigatus a tryptophan-derived iron(III)-complex, hexadehydro-astechrome (HAS), was found to be the major product of the cryptic has nonribosomalpeptide synthetase (NRPS) cluster. In A. flavus we show that two separate clusters encode enzymes that produce partially overlapping sets ofnovel piperazines, pyrazines, and morpholines. These L-tyrosine metabolites are activated by two NRPS-like proteins, LnaA and LnbA. Loss andoverexpression of these metabolites impacted fungal development in these species.The KMT6 Histone H3 K27 Methyltransferase Regulates Expression of Secondary Metabolites and Development in Fusarium graminearum. Kristina M.Smith, Lanelle R. Connolly, Michael Freitag. Department of Biochemistry and Biophysics, Center for Genome Research and Biocomputing, Oregon StateUniversity, Corvallis, OR 97331.The cereal pathogen Fusarium graminearum produces secondary metabolites toxic to humans and animals, yet coordinated transcriptional regulation ofsecondary metabolite gene clusters remains largely a mystery. By ChIP-sequencing we found that regions of the F. graminearum genome with secondarymetabolite clusters are enriched for a histone modification, trimethylated histone H3 lysine 27 (H3K27me3), associated with gene silencing. Thismodification was found predominantly in regions that lack synteny with other Fusarium species, generally subtelomeric regions. H3K27me3 and di- ortrimethylated H3K4 (H3K4me2/3), modifications associated with gene activity, are found in mutually exclusive regions of the genome. To betterunderstand the role of H3K27me3, we deleted the gene for the putative H3K27 methyltransferase, KMT6, a homolog of Drosophila Enhancer of zeste, E(z).The kmt6 mutant lacks H3K27me3, as shown by western blot and ChIP-sequencing, displays growth defects, is sterile, and produces mycotoxins underconditions where they are not generated in wildtype (WT) strains. RNA-sequencing showed that genes modified by H3K27me3 are most often silent, asabout 75% of the 4,449 silent genes are enriched for H3K27me3. Surprisingly, we found 22% of the 8,855 expressed genes enriched for H3K27me3. Asubset of genes that were enriched for H3K27me3 in WT gained H3K4me2/3 in kmt6 (1,780 genes), and an overlapping set of genes showed increasedexpression. Almost 95% of the remaining 2,720 annotated silent genes showed no enrichment for either H3K27me3 or H3K4me2/3. In these cases absenceof H3K27me3 is insufficient for expression, which suggests a requirement for additional factors for gene expression. Taken together, we show that absenceof H3K27me3 allows expression of 14% of all annotated genes, resulting in derepression of predominantly secondary metabolite pathways and otherspecies-specific functions, including potentially secreted pathogenicity factors. This study provides the framework for novel targeted strategies to controlthe “cryptic genome” and specifically secondary metabolite expression.88
CONCURRENT SESSION ABSTRACTSSecondary metabolism in Botrytis cinerea: the grey and pink sides of a pathogen. M. Viaud 1 , H. Sghyer 1 , J. Schumacher 2 , A. Simon 1 , B. Dalmais 1 , J.M.Pradier 1 . 1) INRA, BIOGER, Av. L. Brétignières, 78850 Grignon, France; 2) Department of Botany and Plant Pathology, Purdue University, West Lafayette, IN47906, USA.Sequencing the genome of the grey mould fungus Botrytis cinerea revealed 40 secondary metabolism (SM) gene clusters corresponding to thebiosynthesis of mostly unknown compounds including polyketides (21), terpenes (11) and non-ribosomal peptides (8). The two identified phytotoxicmetabolites are the polyketide botcinic acid (BOA) and the sesquiterpene botrydial (BOT). Transcriptomic studies previously identified the correspondingBOA and BOT gene clusters. Deletion of the key enzyme BcBOA6 (PolyKetide Synthase) or BcBOT2 (SesquiTerpene Cyclase) encoding genes did not causeany defects, while bcboa6/bcbot2 double mutants were significantly impaired in necrotrophic development on several hosts suggesting that the twocompounds have a redundant function. We are currently investigating how the BOT and BOA gene clusters are regulated: The BOA cluster contains a gene(bcboa13) encoding a C6H6 zinc finger transcription factor (TF). Surprisingly, while bcboa6 mutant has no virulence defect, bcboa13 mutant shows adrastic reduced virulence which is even more pronounced than that of the bcboa6/bcbot2 double mutant lacking both known toxins. A wholetranscriptome analysis of bcboa13 mutant is underway to determine whether other genes apart from those of the BOA cluster are regulated by this TF. Inopposite to the BOA cluster, the BOT cluster does not contain any TF-encoding gene. We therefore set up a Yeast-One-Hybrid library that contains themajority of B. cinerea TFs (393 out of 406) and screened it with the promoter of bcbot2. This led to the identification of a C2H2 TF called BcYOH1.Inactivation of bcyoh1 gene and expression analysis revealed that this TF acts as a global regulator of SM, regulating the expression of genes of the BOT,BOA, and 20 other SM clusters. As in other fungi, the Velvet complex takes part in regulation of light-dependent development and SM in B. cinerea. Geneinactivation of bcvel1, however, does not significantly modify the production of BOA and BOT. Instead, BcVEL1 plays a significant role in the regulation ofoxalic acid (OA) formation and pigmentation: it regulates negatively the synthesis of melanin and positively the synthesis of OA and bikaverin (BIK) anotherpolyketidic pigment that is only produced in rare pink strains of B. cinerea.Is fungal secondary metabolism regulated by competing insects? Annika Regulin 1 , Nancy Keller 2 , Frank Kempken 1 . 1) Department of Botany, Christian-Albrechts University, Kiel, Germany; 2) Department Medical Microbiology and Immunology, Dept of Bacteriology, UW-Madison, USA.Fungi synthesize an astonishing variety of secondary metabolites, some of which belong to the most toxic compounds in the living world. Even thoughlittle is known about the benefit of these metabolites, the ability to regulate the secondary metabolism might be seen as an evolutionary adaptation.Presumably fungi regulate secondary metabolites (e.g. mycotoxin) in response to confrontation with natural competitors like insects to guarantee efficientexploitation of environmental resources (1-3). Admittedly it should be mentioned that secondary metabolites are not the only defence mechanisms offungi (4). In order to enlighten the biological function of these secondary metabolites with reference to chemical defence reactions of insect-fungalinteractions, we utilized complementary approaches of experimental ecology and functional genomic techniques. The vinegar fly Drosophila melanogasterand its natural antagonist Aspergillus nidulans are used as an ecology model system. To analyse fungal up- or down regulated target genes in theinteraction of A. nidulans with Drosophila larvae microarray analysis was performed. This led to the identification of secondary metabolite genes up- ordown-regulated under these conditions. Quantitative RT-PCR was employed to analyze secondary metabolite gene expression at different time points.<strong>Fungal</strong> single, double and triple mutations of identified up-regulated genes are currently analyzed in confrontation assays to identify potentialmodifications in gene expression and the survival rate of larvae concerning to chemical defense reaction of fungus-insect interaction compared to wildtype. This could reveal insights about the biological function of secondary metabolite genes and clusters such as stc and mdp.(1.) Rohlfs, M., Albert, M., Keller, N. P., and Kempken, F. (2007) Biol Lett 3, 523-25. (2.) Kempken, F., and Rohlfs, M. (2010) <strong>Fungal</strong> Ecol 3, 107-14. (3.)Rohlfs, M., Trienens, M., Fohgrub, U., and Kempken, F. (2009) in "The Mycota XV. (Anke, T., Ed.), Springer Heidelberg, New York, Tokyo, pp. 131-51 (4.)Kempken, F. (2011) Mol Ecol 20, 2876-77.<strong>27th</strong> <strong>Fungal</strong> <strong>Genetics</strong> <strong>Conference</strong> | 89
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42: CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44: CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46: CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48: CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50: CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52: CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54: CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56: CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58: CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60: CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62: CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64: CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66: CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68: CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70: CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72: CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74: CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76: CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78: CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80: CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82: CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84: CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86: CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88: CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90: CONCURRENT SESSION ABSTRACTSCommon
- Page 91: CONCURRENT SESSION ABSTRACTSSaturda
- Page 95 and 96: CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98: CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100: CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102: CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104: CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106: CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108: LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110: LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112: LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114: LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116: LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118: LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120: LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122: LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124: LISTING OF ALL POSTER ABSTRACTS640.
- Page 125 and 126: LISTING OF ALL POSTER ABSTRACTS723.
- Page 127 and 128: FULL POSTER SESSION ABSTRACTS5. Cha
- Page 129 and 130: FULL POSTER SESSION ABSTRACTS13. In
- Page 131 and 132: FULL POSTER SESSION ABSTRACTSbioche
- Page 133 and 134: FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136: FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138: FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140: FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142: FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144:
FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146:
FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148:
FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150:
FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152:
FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154:
FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156:
FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158:
FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160:
FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162:
FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164:
FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166:
FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168:
FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170:
FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172:
FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174:
FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176:
FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178:
FULL POSTER SESSION ABSTRACTS212. T
- Page 179 and 180:
FULL POSTER SESSION ABSTRACTSCompar
- Page 181 and 182:
FULL POSTER SESSION ABSTRACTSmore g
- Page 183 and 184:
FULL POSTER SESSION ABSTRACTSmolecu
- Page 185 and 186:
FULL POSTER SESSION ABSTRACTSunexpe
- Page 187 and 188:
FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190:
FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192:
FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194:
FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196:
FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198:
FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200:
FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202:
FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204:
FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206:
FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208:
FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210:
FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212:
FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214:
FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216:
FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218:
FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220:
FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222:
FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224:
FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226:
FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228:
FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230:
FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232:
FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234:
FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236:
FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238:
FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240:
FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242:
FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244:
FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246:
FULL POSTER SESSION ABSTRACTSassess
- Page 247 and 248:
FULL POSTER SESSION ABSTRACTSmating
- Page 249 and 250:
FULL POSTER SESSION ABSTRACTScommon
- Page 251 and 252:
FULL POSTER SESSION ABSTRACTSOne of
- Page 253 and 254:
FULL POSTER SESSION ABSTRACTScells
- Page 255 and 256:
FULL POSTER SESSION ABSTRACTSof Ave
- Page 257 and 258:
FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260:
FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262:
FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264:
FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266:
FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268:
FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270:
FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272:
FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274:
FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276:
FULL POSTER SESSION ABSTRACTSE.elym
- Page 277 and 278:
FULL POSTER SESSION ABSTRACTSThe de
- Page 279 and 280:
FULL POSTER SESSION ABSTRACTSMicrob
- Page 281 and 282:
FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284:
FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286:
FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288:
FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290:
FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292:
FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294:
FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296:
FULL POSTER SESSION ABSTRACTSin the
- Page 297 and 298:
FULL POSTER SESSION ABSTRACTSpotent
- Page 299 and 300:
FULL POSTER SESSION ABSTRACTSpoint
- Page 301 and 302:
FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304:
FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306:
FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308:
KEYWORD LISTABC proteins ..........
- Page 309 and 310:
KEYWORD LISThigh temperature growth
- Page 311 and 312:
AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314:
AUTHOR LISTFrancis, Martin ........
- Page 315 and 316:
AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318:
AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320:
AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322:
AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324:
LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326:
LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328:
LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330:
LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332:
LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334:
LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336:
LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338:
LIST OF PARTICIPANTSAric E WiestUni